 Katrina Claw
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharmacogenetics | 6 | 2025 | 172 | 2.070 |
Why?
| | Cytochrome P-450 CYP2A6 | 6 | 2025 | 8 | 2.000 |
Why?
| | Genetic Research | 4 | 2025 | 17 | 1.830 |
Why?
| | Indians, North American | 8 | 2025 | 597 | 1.730 |
Why?
| | Nicotine | 6 | 2025 | 333 | 1.440 |
Why?
| | Health Services, Indigenous | 2 | 2024 | 36 | 1.330 |
Why?
| | Genomics | 7 | 2025 | 828 | 1.290 |
Why?
| | Evolution, Molecular | 4 | 2018 | 516 | 1.040 |
Why?
| | Research Personnel | 3 | 2025 | 184 | 0.870 |
Why?
| | Neanderthals | 1 | 2023 | 13 | 0.810 |
Why?
| | Attitude | 1 | 2025 | 260 | 0.790 |
Why?
| | Hominidae | 1 | 2023 | 87 | 0.760 |
Why?
| | Paleontology | 2 | 2022 | 20 | 0.700 |
Why?
| | Genotype | 6 | 2021 | 1843 | 0.690 |
Why?
| | Cytochrome P-450 CYP2B6 | 1 | 2020 | 9 | 0.640 |
Why?
| | Alaska Natives | 4 | 2021 | 101 | 0.600 |
Why?
| | Community Participation | 3 | 2025 | 122 | 0.590 |
Why?
| | Semen | 1 | 2018 | 24 | 0.560 |
Why?
| | DNA | 1 | 2023 | 1444 | 0.500 |
Why?
| | Genetic Variation | 5 | 2024 | 982 | 0.490 |
Why?
| | Smoking Cessation | 4 | 2025 | 436 | 0.470 |
Why?
| | Sperm-Ovum Interactions | 1 | 2014 | 12 | 0.420 |
Why?
| | Membrane Glycoproteins | 2 | 2014 | 495 | 0.420 |
Why?
| | Smoking | 2 | 2024 | 1466 | 0.410 |
Why?
| | Immunoglobulins | 1 | 2014 | 159 | 0.400 |
Why?
| | Alaska | 3 | 2021 | 81 | 0.370 |
Why?
| | Glycoproteins | 1 | 2014 | 353 | 0.360 |
Why?
| | Haplotypes | 3 | 2024 | 490 | 0.350 |
Why?
| | DNA, Ancient | 3 | 2022 | 8 | 0.340 |
Why?
| | Oocytes | 1 | 2012 | 178 | 0.340 |
Why?
| | Proteomics | 1 | 2018 | 1182 | 0.340 |
Why?
| | Research | 3 | 2020 | 430 | 0.330 |
Why?
| | Receptors, Serotonin, 5-HT2 | 1 | 2010 | 3 | 0.310 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 17 | 0.310 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2010 | 62 | 0.300 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2024 | 2134 | 0.300 |
Why?
| | Humans | 35 | 2025 | 144298 | 0.280 |
Why?
| | Liver | 6 | 2025 | 1884 | 0.280 |
Why?
| | Membrane Proteins | 1 | 2014 | 1158 | 0.260 |
Why?
| | Genome, Human | 3 | 2025 | 419 | 0.260 |
Why?
| | Pharmacogenomic Testing | 3 | 2024 | 62 | 0.240 |
Why?
| | Alleles | 3 | 2024 | 881 | 0.230 |
Why?
| | Eugenics | 1 | 2025 | 3 | 0.230 |
Why?
| | Human Genetics | 1 | 2025 | 3 | 0.230 |
Why?
| | Tobacco Use Cessation | 1 | 2025 | 28 | 0.210 |
Why?
| | Biological Evolution | 2 | 2023 | 487 | 0.210 |
Why?
| | Whole Genome Sequencing | 1 | 2024 | 183 | 0.200 |
Why?
| | Computational Biology | 2 | 2019 | 679 | 0.190 |
Why?
| | Middle Aged | 11 | 2025 | 35892 | 0.190 |
Why?
| | Australia | 1 | 2023 | 287 | 0.190 |
Why?
| | Adult | 12 | 2025 | 40408 | 0.180 |
Why?
| | Spermatozoa | 2 | 2014 | 107 | 0.180 |
Why?
| | Ethics Committees, Research | 2 | 2018 | 40 | 0.170 |
Why?
| | Cultural Competency | 2 | 2018 | 89 | 0.170 |
Why?
| | Xenobiotics | 1 | 2021 | 31 | 0.160 |
Why?
| | Tissue Banks | 2 | 2018 | 17 | 0.160 |
Why?
| | Male | 13 | 2025 | 72263 | 0.160 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2021 | 93 | 0.160 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2019 | 32 | 0.150 |
Why?
| | Animals | 8 | 2024 | 37800 | 0.150 |
Why?
| | Linkage Disequilibrium | 3 | 2021 | 249 | 0.150 |
Why?
| | MicroRNAs | 1 | 2025 | 689 | 0.140 |
Why?
| | Glucuronosyltransferase | 1 | 2018 | 18 | 0.140 |
Why?
| | Population Groups | 1 | 2018 | 56 | 0.140 |
Why?
| | Sulfotransferases | 1 | 2018 | 6 | 0.140 |
Why?
| | Calcifediol | 1 | 2018 | 31 | 0.130 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2018 | 47 | 0.130 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2019 | 548 | 0.130 |
Why?
| | Sulfates | 1 | 2018 | 49 | 0.130 |
Why?
| | Oxygenases | 1 | 2017 | 12 | 0.130 |
Why?
| | Researcher-Subject Relations | 1 | 2017 | 3 | 0.130 |
Why?
| | Primates | 1 | 2018 | 132 | 0.130 |
Why?
| | New Mexico | 1 | 2017 | 99 | 0.130 |
Why?
| | Delivery of Health Care | 1 | 2024 | 942 | 0.120 |
Why?
| | Reproduction | 1 | 2018 | 205 | 0.120 |
Why?
| | Disease Susceptibility | 1 | 2018 | 342 | 0.120 |
Why?
| | Androgens | 1 | 2018 | 178 | 0.120 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 444 | 0.120 |
Why?
| | Female | 12 | 2025 | 78137 | 0.120 |
Why?
| | Women | 1 | 2016 | 50 | 0.120 |
Why?
| | Gene Frequency | 3 | 2024 | 480 | 0.120 |
Why?
| | Young Adult | 7 | 2025 | 14092 | 0.120 |
Why?
| | Health Services Research | 1 | 2018 | 392 | 0.120 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 6035 | 0.110 |
Why?
| | Microsomes, Liver | 3 | 2021 | 85 | 0.110 |
Why?
| | Urban Population | 1 | 2018 | 493 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 565 | 0.110 |
Why?
| | Mass Spectrometry | 1 | 2018 | 741 | 0.110 |
Why?
| | Aged | 8 | 2025 | 25901 | 0.110 |
Why?
| | Sequence Analysis, DNA | 1 | 2018 | 822 | 0.110 |
Why?
| | Ovum | 1 | 2014 | 31 | 0.100 |
Why?
| | Vitamin D | 1 | 2018 | 400 | 0.100 |
Why?
| | Haplorhini | 1 | 2014 | 52 | 0.100 |
Why?
| | Biomedical Research | 1 | 2020 | 712 | 0.100 |
Why?
| | Phylogeny | 1 | 2018 | 1020 | 0.100 |
Why?
| | Public Health | 1 | 2018 | 563 | 0.100 |
Why?
| | Adolescent | 7 | 2025 | 22370 | 0.100 |
Why?
| | Cell Adhesion Molecules | 1 | 2014 | 178 | 0.100 |
Why?
| | Zona Pellucida Glycoproteins | 1 | 2012 | 2 | 0.090 |
Why?
| | Zona Pellucida | 1 | 2012 | 3 | 0.090 |
Why?
| | Egg Proteins | 1 | 2012 | 20 | 0.090 |
Why?
| | Fertilization | 1 | 2012 | 43 | 0.090 |
Why?
| | Community-Based Participatory Research | 2 | 2025 | 164 | 0.080 |
Why?
| | Communication | 1 | 2017 | 968 | 0.080 |
Why?
| | Receptors, Cell Surface | 1 | 2012 | 370 | 0.080 |
Why?
| | Pan troglodytes | 1 | 2010 | 63 | 0.080 |
Why?
| | Aged, 80 and over | 5 | 2021 | 8265 | 0.070 |
Why?
| | Cell Membrane | 1 | 2012 | 704 | 0.070 |
Why?
| | RNA, Messenger | 3 | 2025 | 2808 | 0.070 |
Why?
| | alpha-Amylases | 1 | 2007 | 11 | 0.070 |
Why?
| | Selection, Genetic | 1 | 2010 | 256 | 0.070 |
Why?
| | Infant | 5 | 2021 | 10011 | 0.060 |
Why?
| | Gene Dosage | 1 | 2007 | 148 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1046 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2021 | 6387 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2021 | 11713 | 0.060 |
Why?
| | Child, Preschool | 5 | 2021 | 11767 | 0.060 |
Why?
| | Human Genome Project | 1 | 2024 | 15 | 0.050 |
Why?
| | Genomic Structural Variation | 1 | 2024 | 13 | 0.050 |
Why?
| | History, 21st Century | 1 | 2025 | 220 | 0.050 |
Why?
| | History, 20th Century | 1 | 2025 | 327 | 0.050 |
Why?
| | Drug Interactions | 1 | 2024 | 401 | 0.050 |
Why?
| | Pharmaceutical Preparations | 1 | 2024 | 170 | 0.050 |
Why?
| | Genetic Testing | 1 | 2025 | 479 | 0.050 |
Why?
| | Nicotinic Agonists | 1 | 2024 | 137 | 0.050 |
Why?
| | Trust | 1 | 2024 | 155 | 0.050 |
Why?
| | Child | 5 | 2021 | 22562 | 0.040 |
Why?
| | Enzyme Assays | 1 | 2021 | 25 | 0.040 |
Why?
| | Pharmacogenomic Variants | 1 | 2021 | 33 | 0.040 |
Why?
| | Informed Consent | 1 | 2022 | 196 | 0.040 |
Why?
| | Dextrorphan | 1 | 2019 | 2 | 0.040 |
Why?
| | Metoprolol | 1 | 2019 | 26 | 0.040 |
Why?
| | Dextromethorphan | 1 | 2019 | 24 | 0.040 |
Why?
| | Foster Home Care | 1 | 2020 | 88 | 0.040 |
Why?
| | United States Indian Health Service | 1 | 2018 | 45 | 0.040 |
Why?
| | Inactivation, Metabolic | 1 | 2018 | 9 | 0.030 |
Why?
| | Research Support as Topic | 1 | 2018 | 79 | 0.030 |
Why?
| | Genetic Loci | 1 | 2019 | 260 | 0.030 |
Why?
| | Information Dissemination | 1 | 2020 | 222 | 0.030 |
Why?
| | Hydroxylation | 1 | 2018 | 49 | 0.030 |
Why?
| | Capacity Building | 1 | 2018 | 62 | 0.030 |
Why?
| | Receptors, Steroid | 1 | 2018 | 41 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2019 | 369 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2018 | 183 | 0.030 |
Why?
| | Umbelliferones | 1 | 2016 | 1 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2018 | 161 | 0.030 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 2016 | 10 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 612 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1055 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2016 | 95 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3139 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1041 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2025 | 1405 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2016 | 268 | 0.030 |
Why?
| | Health Status Disparities | 1 | 2018 | 317 | 0.030 |
Why?
| | Kinetics | 1 | 2018 | 1603 | 0.030 |
Why?
| | Testosterone | 1 | 2018 | 412 | 0.030 |
Why?
| | United States | 2 | 2024 | 15979 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 3520 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2017 | 776 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1565 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1373 | 0.020 |
Why?
| | Starch | 1 | 2007 | 21 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 5948 | 0.020 |
Why?
| | Aging | 1 | 2017 | 1935 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 17104 | 0.010 |
Why?
| | Diet | 1 | 2007 | 1270 | 0.010 |
Why?
|
|
Claw's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|